Blood transfusions play a critical role in the management of sickle cell disease. They can help prevent and manage various complications as well as reduce disease severity. This lifesaving ...
The U.S. Food and Drug Administration (FDA) gave the greenlight for Iomab-ACT, a potentially less toxic conditioning regimen, to be tested in people with sickle cell disease (SCD) undergoing a stem ...